Search Results

There are 6041 results for: content related to: Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine

  1. You have free access to this content
    Novel human CYP2A6 alleles confound gene deletion analysis

    FEBS Letters

    Volume 569, Issue 1-3, July 02, 2004, Pages: 75–81, Miki Nakajima, Ryoko Yoshida, Tatsuki Fukami, Howard L McLeod and Tsuyoshi Yokoi

    Version of Record online : 7 JUN 2004, DOI: 10.1016/j.febslet.2004.05.053

  2. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 1, January 2001, Pages: 72–78, Miki Nakajima, Jun-Tack Kwon, Nobushige Tanaka, Takahiro Zenta, Yasuhiko Yamamoto, Hiroshi Yamamoto, Hiroshi Yamazaki, Toshinori Yamamoto, Yukio Kuroiwa and Tsuyoshi Yokoi

    Version of Record online : 5 JAN 2001, DOI: 10.1067/mcp.2001.112688

  3. You have free access to this content
    Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo

    British Journal of Pharmacology

    Volume 163, Issue 6, July 2011, Pages: 1250–1262, Yune-Fang Ueng, Chien-Chih Chen, Yu-Ting Chung, Tsung-Yun Liu, Yu-Ping Chang, Wei-Sheng Lo, Norie Murayama, Hiroshi Yamazaki, Pavel Souček, Gar-Yang Chau, Chin-Wen Chi, Ruei-Ming Chen and Ding-Tzai Li

    Version of Record online : 27 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01341.x

  4. Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 1, July 2003, Pages: 69–76, Ryoko Yoshida, Miki Nakajima, Kiyoko Nishimura, Shogo Tokudome, Jun-Tack Kwon and Tsuyoshi Yokoi

    Version of Record online : 19 JUL 2003, DOI: 10.1016/S0009-9236(03)00090-0

  5. Functional variants at CYP2A6: New genotyping methods, population genetics, and relevance to studies of tobacco dependence

    American Journal of Medical Genetics

    Volume 96, Issue 5, 9 October 2000, Pages: 638–645, Cyrus P. Zabetian, Joel Gelernter and Joseph F. Cubells

    Version of Record online : 26 OCT 2000, DOI: 10.1002/1096-8628(20001009)96:5<638::AID-AJMG9>3.0.CO;2-R

  6. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 3, September 2006, Pages: 282–297, Miki Nakajima, Tatsuki Fukami, Hiroyuki Yamanaka, Eriko Higashi, Haruko Sakai, Ryoko Yoshida, Jun-Tack Kwon, Howard L. McLeod and Tsuyoshi Yokoi

    Version of Record online : 2 SEP 2006, DOI: 10.1016/j.clpt.2006.05.012

  7. Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants

    Biopharmaceutics & Drug Disposition

    Volume 34, Issue 2, March 2013, Pages: 87–97, Tomohide Uno, Yuichiro Obe, Chika Ogura, Tatsushi Goto, Kohei Yamamoto, Masahiko Nakamura, Kengo Kanamaru, Hiroshi Yamagata and Hiromasa Imaishi

    Version of Record online : 4 DEC 2012, DOI: 10.1002/bdd.1825

  8. You have free access to this content
    Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism

    FEBS Letters

    Volume 460, Issue 2, October 29, 1999, Pages: 321–327, Mikael Oscarson, Roman A. McLellan, Harriet Gullstén, José A.G. Agúndez, Julio Benı́tez, Arja Rautio, Hannu Raunio, Olavi Pelkonen and Magnus Ingelman-Sundberg

    Version of Record online : 25 OCT 1999, DOI: 10.1016/S0014-5793(99)01364-2

  9. You have free access to this content
    Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism

    British Journal of Clinical Pharmacology

    Volume 54, Issue 5, November 2002, Pages: 511–517, Ryoko Yoshida, Miki Nakajima, Yuki Watanabe, Jun-Tack Kwon and Tsuyoshi Yokoi

    Version of Record online : 11 NOV 2002, DOI: 10.1046/j.1365-2125.2002.01667.x

  10. Association between CYP2A6 genetic polymorphisms and lung cancer: A meta-analysis of case–control studies

    Environmental and Molecular Mutagenesis

    Volume 54, Issue 2, March 2013, Pages: 133–140, Tao Liu, Chuan-Bo Xie, Wen-Jun Ma and Wei-Qing Chen

    Version of Record online : 30 NOV 2012, DOI: 10.1002/em.21751

  11. Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids

    Biopharmaceutics & Drug Disposition

    Volume 36, Issue 8, November 2015, Pages: 552–563, Tomohide Uno, Chika Ogura, Chiho Izumi, Masahiko Nakamura, Takeshi Yanase, Hiroshi Yamazaki, Hitoshi Ashida, Kengo Kanamaru, Hiroshi Yamagata and Hiromasa Imaishi

    Version of Record online : 31 AUG 2015, DOI: 10.1002/bdd.1966

  12. The CYP2A6*4 Allele Is Determinant of S-1 Pharmacokinetics in Japanese Patients With Non-small-cell Lung Cancer

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 4, April 2008, Pages: 589–594, Y Kaida, N Inui, T Suda, H Nakamura, H Watanabe and K Chida

    Version of Record online : 23 JAN 2008, DOI: 10.1038/sj.clpt.6100484

  13. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 5, November 2006, Pages: 457–467, Neal L. Benowitz, Gary E. Swan, Peyton Jacob III, Christina N. Lessov-Schlaggar and Rachel F. Tyndale

    Version of Record online : 4 NOV 2006, DOI: 10.1016/j.clpt.2006.08.011

  14. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 1, January 2000, Pages: 57–69, Miki Nakajima, Sho-ichi Yamagishi, Hiroshi Yamamoto, Toshinori Yamamoto, Yukio Kuroiwa and Tsuyoshi Yokoi

    Version of Record online : 5 JAN 2000, DOI: 10.1067/mcp.2000.103957

  15. You have free access to this content
    Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study

    International Journal of Cancer

    Volume 138, Issue 9, 1 May 2016, Pages: 2161–2171, Jian-Min Yuan, Heather H. Nelson, Lesley M. Butler, Steven G. Carmella, Renwei Wang, Jacquelyn K. Kuriger-Laber, Jennifer Adams-Haduch, Stephen S. Hecht, Yu-Tang Gao and Sharon E. Murphy

    Version of Record online : 21 JAN 2016, DOI: 10.1002/ijc.29963

  16. Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 3, March 2005, Pages: 145–158, Viba Malaiyandi, Edward M. Sellers and Rachel F. Tyndale

    Version of Record online : 7 MAR 2005, DOI: 10.1016/j.clpt.2004.10.011

  17. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)

    Addiction

    Volume 109, Issue 1, January 2014, Pages: 128–137, Li-Shiun Chen, A. Joseph Bloom, Timothy B. Baker, Stevens S. Smith, Megan E. Piper, Maribel Martinez, Nancy Saccone, Dorothy Hatsukami, Alison Goate and Laura Bierut

    Version of Record online : 11 NOV 2013, DOI: 10.1111/add.12353

  18. You have free access to this content
    Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population

    International Journal of Cancer

    Volume 95, Issue 2, 20 March 2001, Pages: 96–101, Wen Tan, Gen-Fu Chen, De-Yin Xing, Chun-Ying Song, Fred F. Kadlubar and Dong-Xin Lin

    Version of Record online : 28 FEB 2001, DOI: 10.1002/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2

  19. Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations

    Fundamental & Clinical Pharmacology

    Volume 25, Issue 5, October 2011, Pages: 627–632, Antonia Soriano, Jorge Vicente, Cristina Carcas, Fabricio Gonzalez-Andrade, Izaskún Arenaz, Begoña Martinez-Jarreta, Ana Fanlo, Esteban Mayayo and Blanca Sinués

    Version of Record online : 17 MAR 2011, DOI: 10.1111/j.1472-8206.2010.00889.x

  20. Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 5, November 2011, Pages: 693–700, Z Desta, Y Kreutz, A T Nguyen, L Li, T Skaar, L K Kamdem, N L Henry, D F Hayes, A M Storniolo, V Stearns, E Hoffmann, R F Tyndale and D A Flockhart

    Version of Record online : 5 OCT 2011, DOI: 10.1038/clpt.2011.174